000			01133 a2200301 4500
005			20250515193234.0
264		0	_c20100430
008			201004s 0 0 eng d
022			_a0720-9355
040			_aNLM _beng _cNLM
100	1		_aScharf, R E
245	0	0	_aManagement of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention. _h[electronic resource]
260			_bHamostaseologie _cNov 2009
300			_a388-98 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHemostasis _xdrug effects
650	0	4	_aHumans
650	0	4	_aLiver Cirrhosis _xcomplications
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aThrombolytic Therapy _xadverse effects
650	0	4	_aVitamin K _xtherapeutic use
773	0		_tHamostaseologie _gvol. 29 _gno. 4 _gp. 388-98
999			_c19270653 _d19270653